Supreme Court Asks for Government's View on Bayer's Roundup Case -- Market Talk

Dow Jones

2025/06/30

1108 ET - The Supreme Court has asked the Trump administration for its view in Bayer's latest bid to challenge the Roundup weedkiller litigation that has cost it billions of dollars. Bayer's latest attempt to get the court to narrow the litigation that has dogged it for nearly a decade argues that users of Roundup can't sue it because regulators have said glyphosate, the main ingredient, doesn't require a cancer warning label. Bayer will now have to wait several more months for a decision. "We see this request as an encouraging step and look forward to hearing the views of the government," said Bayer CEO Bill Anderson in a statement. Analysts at BMO Capital Markets had given the company a 20% to 25% chance of a favorable ruling if SCOTUS requested an opinion from the solicitor general. (patrick.thomas@wsj.com)

(END) Dow Jones Newswires

June 30, 2025 11:09 ET (15:09 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2547901342"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2547901342\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2547901342?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-30 23:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2547901342","market":"hk","top_or_hot":-1,"title":"Supreme Court Asks for Government's View on Bayer's Roundup Case -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1108 ET - The Supreme Court has asked the Trump administration for its view in Bayer's latest bid to challenge the Roundup weedkiller litigation that has cost it billions of dollars. Bayer's latest attempt to get the court to narrow the litigation that has dogged it for nearly a decade argues that users of Roundup can't sue it because regulators have said glyphosate, the main ingredient, doesn't require a cancer warning label. Bayer will now have to wait several more months for a decision. \"We see this request as an encouraging step and look forward to hearing the views of the government,\" said Bayer CEO Bill Anderson in a statement. Analysts at BMO Capital Markets had given the company a 20% to 25% chance of a favorable ruling if SCOTUS requested an opinion from the solicitor general. (patrick.thomas@wsj.com) \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 30, 2025 11:09 ET (15:09 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Supreme Court Asks for Government's View on Bayer's Roundup Case -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSupreme Court Asks for Government's View on Bayer's Roundup Case -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-06-30 23:09</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1108 ET - The Supreme Court has asked the Trump administration for its view in Bayer's latest bid to challenge the Roundup weedkiller litigation that has cost it billions of dollars. Bayer's latest attempt to get the court to narrow the litigation that has dogged it for nearly a decade argues that users of Roundup can't sue it because regulators have said glyphosate, the main ingredient, doesn't require a cancer warning label. Bayer will now have to wait several more months for a decision. \"We see this request as an encouraging step and look forward to hearing the views of the government,\" said Bayer CEO Bill Anderson in a statement. Analysts at BMO Capital Markets had given the company a 20% to 25% chance of a favorable ruling if SCOTUS requested an opinion from the solicitor general. (patrick.thomas@wsj.com) \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 30, 2025 11:09 ET (15:09 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BAYRY","symbol_name":"Bayer A.G.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2547901342","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2547901342","pubTimestamp":1751296140,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1108 ET - The Supreme Court has asked the Trump administration for its view in Bayer's latest bid to challenge the Roundup weedkiller litigation that has cost it billions of dollars. Bayer's latest attempt to get the court to narrow the litigation that has dogged it for nearly a decade argues that users of Roundup can't sue it because regulators have said glyphosate, the main ingredient, doesn't require a cancer warning label. Bayer will now have to wait several more months for a decision. \"We see this request as an encouraging step and look forward to hearing the views of the government,\" said Bayer CEO Bill Anderson in a statement. Analysts at BMO Capital Markets had given the company a 20% to 25% chance of a favorable ruling if SCOTUS requested an opinion from the solicitor general. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BAYRY":"Bayer A.G.","BK4007":"制药"},"translate_title":"最高法院征求政府对拜耳农达案的看法——市场谈话","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BAYRY":0.9},"content_text":"1108 ET - The Supreme Court has asked the Trump administration for its view in Bayer's latest bid to challenge the Roundup weedkiller litigation that has cost it billions of dollars. Bayer's latest attempt to get the court to narrow the litigation that has dogged it for nearly a decade argues that users of Roundup can't sue it because regulators have said glyphosate, the main ingredient, doesn't require a cancer warning label. Bayer will now have to wait several more months for a decision. \"We see this request as an encouraging step and look forward to hearing the views of the government,\" said Bayer CEO Bill Anderson in a statement. Analysts at BMO Capital Markets had given the company a 20% to 25% chance of a favorable ruling if SCOTUS requested an opinion from the solicitor general. (patrick.thomas@wsj.com) \n\n\n  (END) Dow Jones Newswires\n\n\n  June 30, 2025 11:09 ET (15:09 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}